Results 61 to 70 of about 802,486 (287)
De novo acute infection and reactivation of hepatitis B virus in established cirrhosis. [PDF]
, 1979 A Theodossi +6 more
openalex +1 more source
Advanced Science, EarlyView.Structural modification of clofoctol yielded a novel blood‐brain barrier‐permeable compound, B7, featuring a multi‐substituted diaryl scaffold. B7 demonstrates potent anti‐glioblastoma activity by suppressing glioblastoma stem cells proliferation, migration, and invasion through interactions with five key residues of poliovirus receptor cell adhesion ...
Yong‐jian Wang +9 more
wiley +1 more source
Inability to Detect Hepatitis B Virus or Specific Antigens in Transformed Chimpanzee Lymphocytes [PDF]
, 1974 Charles A. Schable +4 more
openalex +1 more source
Advanced Science, EarlyView.This review combines the current status of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeat)‐based molecular diagnostic technology to expound the necessity and challenges faced in promoting the development of one‐pot detection. Besides, the focus is on a comprehensive summary and incisive analysis of emerging strategies for one‐pot ...
Hongyan Liu +10 more
wiley +1 more source
Routine use of counter-immunoelectrophoresis test for detecting antibody to hepatitis B virus core antigen. [PDF]
, 1978 Rebecca Freeman, M.H. Hambling
openalex +1 more source
NamiRNA‐Enhancer Network: The Changing Era Challenge and Chance of miRNA
Advanced Science, EarlyView.MiRNAs (miRNAs) regulate diverse biological processes across species. Unlike canonical miRNA‐mediated gene repression, Nuclear Activating miRNAs (NamiRNAs) can efficiently upregulate gene expression by targeting enhancers. This review systematically summarizes recent advances in NamiRNA research, elucidates the theory of NamiRNA‐Enhancer‐mediated Gene ...
Lu Chen +13 more
wiley +1 more source
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
Journal of Hepatology, 2017 P. Lampertico +7 more
semanticscholar +1 more source
Recent Developments in Nanoparticle‐Hydrogel Hybrid Materials for Controlled Release
Advanced Science, EarlyView.This review highlights recent advances in nanoparticle–hydrogel hybrid materials for controlled drug delivery. It explores diverse nanocarrier–hydrogel combinations, drug loading strategies, release mechanisms, and stimuli‐responsive behaviors. Emphasis is placed on the molecular interactions driving hybrid material performance, offering insights into ...
Yiping Fan +8 more
wiley +1 more source
Advanced Science, EarlyView.The limited understanding of IGFR pathway activation hinders its clinical application in HCC. Here, IGFRIL is identified as a novel non‐coding activator of the IGF1R, which recruits PTBP1 to destabilize IGFBP3 mRNA and activates IGF1R, and proposes IGFRIL as a novel actionable target for HCC patients.
Jing Zhang +28 more
wiley +1 more source